Neogen Corp Stock Ownership - Who owns Neogen?

Insider buying vs selling

Have Neogen Corp insiders been buying or selling?
Douglas Edward JonesChief Operating Officer2024-04-1710,000$12.36
James C. BorelDirector2024-04-117,500$13.07
David H. NaemuraCFO2024-04-1012,500$12.51
John Edward AdentCEO2024-04-1023,000$12.36
William T. BoehmDirector2023-11-032,000$16.06
Douglas Edward JonesChief Operating Officer2023-10-2510,000$15.17
Jason Warren LillyVice President2023-10-13351$15.10
James P. TobinDirector2023-10-123,000$15.19
William T. BoehmDirector2023-10-112,591$15.61
David H. NaemuraCFO2023-10-1110,000$15.03

1 of 2

NEOG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NEOG insiders and whales buy or sell their stock.

NEOG Shareholders

What type of owners hold Neogen Corp stock?
Blackrock Inc11.47%24,852,060$288.53MInstitution
Vanguard Group Inc9.02%19,546,737$226.94MInstitution
Norges Bank8.40%18,189,674$211.18MInstitution
Wasatch Advisors LP4.31%9,345,783$108.50MInstitution
Select Equity Group LP3.86%8,365,600$97.12MInstitution
Baillie Gifford Co3.83%8,286,714$96.21MInstitution
William Blair Investment Management LLC3.48%7,536,169$87.49MInstitution
State Street Corp3.44%7,460,004$86.61MInstitution
Conestoga Capital Advisors LLC3.15%6,817,600$79.15MInstitution
Bamco Inc3.06%6,624,299$76.91MInstitution

1 of 3

NEOG vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NEOG98.57%1.43%Net BuyingNet Buying
GH64.42%35.58%Net SellingNet Selling
SHC61.96%38.04%Net SellingNet Selling
RDNT64.36%35.64%Net Selling

Neogen Stock Ownership FAQ

Who owns Neogen?

Neogen (NASDAQ: NEOG) is owned by 106.91% institutional shareholders, 1.56% Neogen insiders, and 0.00% retail investors. James L. Herbert is the largest individual Neogen shareholder, owning 2.20M shares representing 1.01% of the company. James L. Herbert's Neogen shares are currently valued at $25.89M.

If you're new to stock investing, here's how to buy Neogen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.